BHC250502P8000
- 0.00
- 0.000.00%
Bausch Health Newsroom
TD Cowen Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $7
Bausch Health Companies: Hold Rating Amid Lowered Earnings and Profitability Concerns
Bausch Health Is Maintained at Sector Perform by RBC Capital
Bausch Health Companies Analyst Ratings
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Raises Target Price to $10
Shareholders in Bausch Health Companies (NYSE:BHC) Have Lost 68%, as Stock Drops 3.3% This Past Week
Bausch Health | 10-Q: Q1 2025 Earnings Report
BofA Securities Maintains Bausch Health(BHC.US) With Sell Rating, Maintains Target Price $5
Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating
RBC on Bausch Health's Q1
Express News | Bausch Health Companies Inc : RBC Raises Target Price to $10 From $8.5
Cautious Outlook on Bausch Health: Sell Rating Amid Strategic Uncertainty and Tariff Concerns
Bausch Health Companies Inc (BHC) Q1 2025 Earnings Call Highlights: Revenue Growth and ...
Bausch Health (BHC) Q1 Earnings and Revenues Lag Estimates
Earnings Call Summary | Bausch Health(BHC.US) Q1 2025 Earnings Conference
Bausch Health Companies Inc: INTERIM MDA EN
Bausch Health Companies Inc: INTERIM FINANCIAL STATEMENTSREPORT EN
Bausch Health Down 3.8% After Hours as It Reports a Lower Q1 Adjusted Profit
Bausch Health Reports Strong Q1 2025 Results With Revenue Growth and Strategic Refinancing
Bausch Health Maintaining FY25 Rev and Adj EBITDA Guidance >BHC